- Updated: HIV Resistance Assays (6/20/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (6/14/23)
- Updated: COVID-19 Immunization Recommendations (6/8/23)
- FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process (6/6/23)
- NYSDOH AI: Bicillin L-A Manufacturing and Supply Shortage Coinciding with Continued Syphilis Increases (6/6/23)
- NYSDOH AI: Call for Abstracts: 2023 Ending the Epidemic Summit & World AIDS Day Events (6/1/23)
- FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults (5/25/23)
- FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (5/23/23)
- NYSDOH AI Dear Colleague Letter: New York State’s continued response to mpox (5/19/23)
- Topics, Trends & Updates for May (5/11/23)